-
1
-
-
0028305321
-
Protein Purification: Aspects of Processes for Pharmaceutical Products
-
Berthold, W., Walter, J.K., Protein Purification: Aspects of Processes for Pharmaceutical Products, Biologicals, 1994, vol 22, pp. 135-150.
-
(1994)
Biologicals
, vol.22
, pp. 135-150
-
-
Berthold, W.1
Walter, J.K.2
-
2
-
-
0030346952
-
-
eds. Brown, F., Lubiniecki, A.S., Dev Biol Stand, Karger, Basel
-
Walter, J.K., Werz, W., Berthold, W., in: Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products, eds. Brown, F., Lubiniecki, A.S., Dev Biol Stand, Karger, Basel, 1996, vol 88, pp. 99-108.
-
(1996)
Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products
, vol.88
, pp. 99-108
-
-
Walter, J.K.1
Werz, W.2
Berthold, W.3
-
3
-
-
0027016748
-
Experimental approaches to guarantee minimal risk of potential virus in purified monoclonal antibodies
-
Berthold, W., Walter, J.K., Werz, W., Experimental approaches to guarantee minimal risk of potential virus in purified monoclonal antibodies, Cytotechnology, 1992, vol 9, pp. 189-201.
-
(1992)
Cytotechnology
, vol.9
, pp. 189-201
-
-
Berthold, W.1
Walter, J.K.2
Werz, W.3
-
4
-
-
0013666283
-
Virus Removal and Inactivation
-
Walter, J.K., Werz, W., Berthold, W., Virus Removal and Inactivation, BFE, 1992, vol 9, no 9, pp. 560-564.
-
(1992)
BFE
, vol.9
, Issue.9
, pp. 560-564
-
-
Walter, J.K.1
Werz, W.2
Berthold, W.3
-
5
-
-
85064616991
-
Validation of Downstream Process
-
eds. Hauser, H., Wagner. R. Walter de Gruyter: Berlin, New York
-
Walter, J.K., Allgaier, H., Validation of Downstream Process, in: Mammalian Cell Biotechnology in Protein Production, eds. Hauser, H., Wagner. R. Walter de Gruyter: Berlin, New York, 1997, pp. 453-482.
-
(1997)
Mammalian Cell Biotechnology in Protein Production
, pp. 453-482
-
-
Walter, J.K.1
Allgaier, H.2
-
6
-
-
0004125932
-
-
FDA, Rockville, MD, USA
-
U.S. Department of Health and Human Services, Center for Biologies Evaluation and Research, Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use, FDA, Rockville, MD, USA, 1997.
-
(1997)
Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human use
-
-
-
9
-
-
0347266189
-
Microwave Heat Inactivation of Virus: Resistance of Pharmaceutical Proteins Exposed to High Temperature Short Time Heat Treatment
-
Philadelphia, PA, USA, Oct 27-28
-
Walter, J.K., Winter, H., Striffler, U., Microwave Heat Inactivation of Virus: Resistance of Pharmaceutical Proteins Exposed to High Temperature Short Time Heat Treatment, IBC's Symposium on Viral Clearance, Philadelphia, PA, USA, Oct 27-28, 1997.
-
(1997)
IBC's Symposium on Viral Clearance
-
-
Walter, J.K.1
Winter, H.2
Striffler, U.3
|